Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002433046 | SCV002742028 | pathogenic | Hereditary cancer-predisposing syndrome | 2021-07-13 | criteria provided, single submitter | clinical testing | The c.2520_2521dupAG pathogenic mutation, located in coding exon 17 of the BRIP1 gene, results from a duplication of AG at nucleotide position 2520, causing a translational frameshift with a predicted alternate stop codon (p.A841Efs*5). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. |
Myriad Genetics, |
RCV003336739 | SCV004045080 | pathogenic | Familial cancer of breast | 2023-06-07 | criteria provided, single submitter | clinical testing | This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation. |